乳腺对比增强X线摄影(CEM)用于乳腺癌患者随访:利弊辩论
有乳腺癌个人史的女性局部复发或新发原发乳腺癌风险增加,国际指南仅推荐乳腺X线摄影随访,但治疗后尤其前5年乳腺X线摄影敏感度因腺体致密或治疗后改变而降低。本专题报告以专家辩论形式列出支持与反对用MRI或CEM随访的论据,并总结科学要点,提出个体化随访策略:多数患者以乳腺X线摄影为基线,复发风险较高者选择性使用MRI或CEM。
要点
- 有乳腺癌个人史者局部复发或新发原发乳腺癌风险增加,随访旨在最早分期检出复发。
- 国际指南目前仅推荐乳腺X线摄影作为随访影像手段,但治疗后尤其前5年其敏感度降低。
- 腺体致密或50岁前确诊者可能从附加MRI/CEM成像中获益,支持个体化随访。
核心结论
- 对保乳治疗后随访影像采取个体化方法可优化患者结局:多数患者以乳腺X线摄影为基线,复发风险较高者选择性使用MRI或CEM。
研究设计与样本
- 本专题报告以乳腺影像专家辩论形式,列出支持与反对用MRI或CEM进行乳腺癌随访的论据,并总结利弊的科学要点。
诊断标准与关键数值
- 国际指南推荐的随访影像技术仅为乳腺X线摄影。
- 乳腺X线摄影在乳腺癌治疗后尤其前5年敏感度较低,与腺体致密或治疗后改变有关。
- MRI或CEM等对比增强乳腺成像对恶性强化非常敏感,尤其在致密乳腺中。
临床应用与阅片要点
- 有乳腺癌个人史者随访旨在最早分期检出复发,以利及时治疗并可能改善总生存。
- 多数患者可以乳腺X线摄影作为随访基线,复发风险较高者可选择性使用MRI或CEM。
- 腺体致密、50岁前确诊或第二乳腺癌风险增加者,可能从附加MRI/CEM成像中获益。
- 因局部复发后的生存似乎取决于初诊分期,成像应更聚焦于检出最早期的肿瘤。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Women with a personal history of breast cancer (PHBC) are at an increased risk of either a local recurrence or a new primary breast cancer. Thus, surveillance is essential for the detection of recurrent disease at the earliest possible stage, allowing for prompt treatment, and potentially improving overall survival. Nowadays, mammography follow-up is the only surveillance imaging technique recommended by international guidelines. Nevertheless, sensitivity of mammography is lower after breast cancer treatment, particularly during the first 5 years, due to increased density or post-treatment changes. Contrast-enhanced breast imaging techniques, such as MRI or contrast-enhanced mammography (CEM), are very sensitive to detect malignant enhancement, especially in dense breasts. This Special Report will provide arguments in favor of and against breast cancer follow-up with MRI or CEM, in a debate style between experts in Breast Imaging. Finally, the scientific points of pros and cons arguments will be summarized to help objectively decide the best follow-up strategy for women with a personal history of breast cancer. CLINICAL RELEVANCE STATEMENT: A personalized approach to follow-up imaging after conservative breast cancer treatment could optimize patient outcomes, using mammography as a baseline for most patients, and MRI or CEM selectively in patients with higher risks for a recurrence. KEY POINTS: • Women with a personal history of breast cancer are at an increased risk of either a local recurrence or a new primary breast cancer. • Breast cancer survivors may benefit from additional imaging with MRI/CEM, in case of increased risk of a second breast cancer, with dense breasts or a cancer diagnosis before age 50 years. • As survival after local recurrence seems to depend on the initial stage at diagnosis, imaging should be more focused on detecting tumors in the earliest stages.
引用
- Camps-Herrero J, Pijnappel R, Balleyguier C, et al. MR-contrast enhanced mammography (CEM) for follow-up of breast cancer patients: a "pros and cons" debate. Eur Radiol. 2024. PMID: 38488968. doi:10.1007/s00330-024-10684-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。